Fuzhengpaidu granule regulates immune activation molecules CD38 and human leukocyte antigen-D related on CD4+ and CD8+ T cells in patients with acquired immunodeficiency syndrome/human immunodeficiency virus

Journal of Traditional Chinese Medicine

Volumn 33, Issue 4, 2013, Pages 439-443

  Jiang, Feng ^a   Zhang, Rongxin ^a   Gu, Zhenfang ^b   Zhang, Huailing ^b   Guo, Huijun ^b   Deng, Xin ^a   Liang, Jian ^a  

^a RUIKANG HOSPITAL AFFILIATED TO GUANGXI UNIVERSITY OF CHINESE MEDICINE   (China)

^b THE FIRST AFFILIATED HOSPITAL OF HENAN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Acquired immunodeficiency syndrome; Activated leukocyte cell adhesion molecule; Fuzhengpaidu granule; HIV; HLA DR antigens; Immunocompetence

Indexed keywords

CD38 ANTIGEN; CHINESE DRUG; FUZHENGPAIDU GRANULE; HLA DR ANTIGEN; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AIDS PATIENT; ARTICLE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNOREGULATION; LYMPHOCYTE COUNT; MALE; OUTCOME ASSESSMENT; OUTPATIENT; TREATMENT DURATION;

EID: 84882940418     PISSN: 02552922     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0254-6272(13)60145-4     Document Type: Article

References (22)

1. Wang D N, Guo H J, Li H W, Jiang Z Q, Liu X W, Jiang F. Clinical observation on 65 cases of HIV asymptomatic carriers treated by Fuzhengpaidu Tablet II. Zhong Hua Zhong Yi Yao Za Zhi 2009;24(3):385-388.
2. Jiang F, Peng B, Guo H J, Li Q Y, Ren W H. Influence of Fuzhengpaidu Tablet on plasma MBL in asymptomatic HIV carriers. Shi Zhen Guo Yi Guo Yao 2010; 21(2): 329-330.
3. Zhang H Y, Zhang H X, Wang Y C. Fuzhengpaidu Tablets effect on the HIV virus load. Shi Zhen Guo Yi Guo Yao 2008;19(9):2095-2096.
4. Peng B, Liu X W, Guo H J. Effect of Fuzhengpaidu Pian on the changes of CD4+ T lymphocytes in early infective phase of asymptomatic human immunodeficiency virus. Zhong Guo Zu Zhi Gong Cheng Yu Lin Chuang Kang Fu 2007;11(33):6712-6716.
5. Chinese Medical Association and Chinese Center for Disease Control and Prevention. Guidelines for diagnosis and treatment of HIV/AIDS in China (2005). Zhong Hua Yi Xue Za Zhi 2006;119(19):1589-1608.
6. Jiang F. Immune activation is an important point-cut of Chinese medicine on HIV/AIDS. Zhong Hua Zhong Yi Yao Za Zhi 2011;26(9):2033-2036.
7. Sodora D L, Silvestri G. Immune activation and AIDS pathogenesis. AIDS 2008;22(4):439-446.
8. Vajpayee M, Kaushik S, Sreenivas V, Mojumdar K, Mendiratta S, Chauhan N K. Role of immune activation in CD4+ T-cell depletion in HIV-1infected Indian patients. Eur J Clin Microbiol Infect Dis 2009;28(1):69-73.
9. Li T S, Qiu Z F, Wang A X, Sheng R Y. T-lymphocyte immune in HIV-infected people and AIDS patients in China. Zhong Hua Yi Xue Za Zhi 2002; 82(20): 1391-1395.
10. Benito JM, López M, Lozano S, Martinez P, González-Lahoz J, Soriano V. CD38expression on CD8T lymphocytes as a marker of residual virus replication in chronically HIV-infected patients receiving antiretroviral therapy. AIDS Res Hum Retroviruses 2004;20(2):227-233.
11. Crespo M, Caragol I, Falcó V, Ribera E, Urban S, Pahissa A. Efficacy of recombinant interleukin-2 (rIL-2) in patients with advanced HIV-1 infection and blunted immune response to HAART. Enferm Infecc Microbiol Clin 2008;26(1):27-31.
12. Braunwald Fauci, Kasper Hauser, Longo Jameson. Transltted by Wang DB. Harrison's Principles of Internal Medicine (15th). Beijing: People's Medical Publishing House, 2003:2280, 2293.
13. Giorgi J V, Liu Z, Hultin L E, Cumberland W G, Hennessey K, Detels R. Elevated levels of CD38+ CD8+ T cells in HIV infection add to the prognostic value of low CD4+T cell levels: results of 6 years of follow-up. The Los Angeles Center, Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr 1993;6(8):904-912.
14. Wang X C, Wu H, Li T S, et al. Expression of CD38HLA-DR on CD4+ and CD8+ T lymphocytes in peripheral blood of people living with HIV/AIDS. Zhong Guo Ai Zi Bing Xing Bing 2003;9(1):1-4.
15. Nakanjako D, Ssewanyana I, Mayanja-Kizza H, et al. High T-cell immune activation and immune exhaustion among individuals with suboptimal CD4recovery after 4 years of antiretroviral therapy in an African cohort. BMC Infect Dis 2011;11(11):43.
16. Vajpayee M, Kaushik S, Sreenivas V, Mojumdar K, Mendiratta S, Chauhan N K. Role of immune activation in CD4+ T-cell depletion in HIV-1infected Indian patients. Eur J Clin Microbiol Infect Dis 2009;28(1):69-73.
17. Piconi S, Trabattoni D, Gori A, et al. Immune activation, apoptosis, and Treg activity are associated with persistently reduced CD4+ T-cell counts during antiretroviral therapy. AIDS 2010;24(13):1991-2000.
18. Kelley C F, Kitchen C M, Hunt P W, et al. Incomplete peripheral CD4+ cell count restoration in HIV-infected patients receiving long-term antiretroviral treatment. Clin Infect Dis 2009;48(6):787-794.
19. Negredo E, Massanella M, Puig J, et al. Nadir CD4T cell count as predictor and high CD4T cell intrinsic apoptosis as final mechanism of poor CD4T cell recovery in virologically suppressed HIVinfected patients: clinical implications. Clin Infect Dis 2010;50(9):1300-1308.
20. Han Y, Qiu Z F, Li T S, et al. The correlations between CD8+ CD38+, CD8+ HLA-DR + proportion and HIV load of HIV/AIDS. Zhong Guo Shi Yong Nei Ke Za Zhi 2007;27(11):847-850.
21. Hunt P W, Brenchley J, Sinclair E, et al. Relationship between T cell activation and CD4+T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy. J Infect Dis 2008; 197(1):126-133.
22. Hunt P W, Cao H L, Muzoora C, et al. Impact of CD8+T-cell activation on CD4+ T-cell recovery and mortality in HIV-infected Ugandans initiating antiretroviral therapy. AIDS 2011;25(17):2123-2131.